Torax Medical, Inc. is a privately held medical device company founded in 2002 and headquartered in St. Paul, Minnesota. The company specializes in developing products utilizing its Magnetic Sphincter Augmentation (MSA) technology platform to treat sphincter disorders. Their flagship products include the LINX® Reflux Management System for treating GERD and the FENIX® Continence Restoration System for treating Fecal Incontinence (FI).
In July 2016, Torax Medical secured a significant $25.00M Series E investment from a group of prominent investors including Kaiser Permanente Ventures, Accuitive Medical Ventures, Mayo Clinic Ventures, Sanderling Ventures, Thomas, McNerney & Partners, Piper Jaffray, Johnson & Johnson Robotics, and Digital Solutions.
With a focus on the biotechnology and healthcare industries, Torax Medical is well-positioned to leverage its innovative technology and strong investor backing to make a lasting impact in the medical device market.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series E | $25.00M | 7 |
|
26 Jul 2016 |
| Venture Round | $13.70M | - | 27 Dec 2013 | |
| Debt Financing | $3.00M | - | 24 Sep 2012 | |
| Series D | $30.00M | 6 |
|
19 Sep 2012 |
| Debt Financing | $4.00M | - | 31 May 2011 |
No recent news or press coverage available for Torax Medical, Inc..
We care about your data, and we'd love to use cookies make your experience better.
